The last two Medline ( http://www.ncbi.nlm.nih.gov/ )listed publications of
JT Sparrow at his old address at Baylor College are dated from the end of
1996:
Large-pore polydimethylacrylamide resin for solid-phase peptide synthesis:
applications in Fmoc chemistry. Sparrow JT, Knieb-Cordonier NG, Obeyseskere
NU, McMurray JS, Baylor College of Medicine, Houston, TX, USA. Pept Res 1996
Nov-Dec;9(6):297-304
Improvements to the TMSBr method of peptide resin deprotection and cleavage:
application to large peptides. Sparrow JT, Monera OD, Department of
Medicine, Baylor College of Medicine, Houston, TX 77030, USA.
Also in 1996, JT Sparrow was a second author of a paper in the field of
peptide-based gene therapy
Gene Ther 1996 May;3(5):48-57 A novel DNA-peptide complex for efficient gene
transfer and expression in mammalian cells. Gottschalk S, Sparrow JT, Hauer
J, Mims MP, Leland FE, Woo SL, Smith LC; Department of Cell Biology, Baylor
College of Medicine, Houston, Texas, USA.
If we assume that peptide-based gene therapy remained his major topic, we
can deduce that the new address of Dr. Sparrow should be related to an
article that appeared two years later (only 11 months ago), in June 1998:
Biophys J 1998 Jun;74(6):2802-14. A physicochemical approach for predicting
the effectiveness of peptide-based gene delivery systems for use in
plasmid-based gene therapy. Duguid JG, Li C, Shi M, Logan MJ, Alila H,
Rolland A, Tomlinson E, Sparrow JT, Smith LC; GeneMedicine, The Woodlands,
Texas 77381-4248, USA. biojohn@aol.com
GeneMedicine is easy to find ( using www.yahoo.com )at www.genemedicine.com
GeneMedicine
8301 New Trails Drive
The Woodlands, TX 77381-4248
Tel: 281-364-1150
Fax: 281-364-0858
If you call them or if you e-mail to info@genemedicine.com or to
biojohn@aol.com , you may find the answer. Generally speaking, all authors
of an article in a peer-reviewed journal are required to sign papers about
transfer of author's rights to the publisher, therefore even if JT Sparrow
is not at GeneMedicine aka Valentis, they will most probably know his
current address.
(some related info: MEGABIOS AND GENEMEDICINE COMPLETE MERGER , COMBINED
COMPANY TO BE NAMED VALENTIS, INC. March 16, 1999
THE WOODLANDS, TX, January 18, 1999-- GeneMedicine, inc. (Nasdaq: GMED)
announced today that it has rationalized its work force by reducing it by
approximately one fourth, affecting 26 employees. "The reductions were
company-wide and were made to conserve cash and to position the Company for
its pending merger with Megabios, which is on track for a closing before the
end of this quarter," stated Norman Hardman, Ph.D., President and Chief
Operating Officer of GeneMedicine.)
Regards,
victor@alphadna.com
-----Original Message-----
From: Brian Wallstin <Brian_Wallstin@houstonpress.com>
To: Recipients of ABRF List <abrf@aecom.yu.edu>
Date: May 14, 1999 3:27 PM
Subject: Calling Dr. Sparrow
>To whom it may concern: I came across this e-mail address while searching
for a
>Dr. James T. Sparrow, formerly of Baylor College of Medicine. I know Dr.
Sparrow
>has left Baylor, but was hoping that perhaps some of his colleagues might
know
>how I can reach him. I wish to discuss with him the development of a
hepatitis b
>vaccine, research that, I understand, he was once quite active.
>Thanks to anyone who could help me.
>
>I am,
>
>Brian Wallstin
>Houston, Tx.
>713-280-2481